drugset / Trial / NCT00565162

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus

NCT00565162 ↗

Phase 4 Completed 124 enrolled Sanofi
RandomizedParallel-groupOpen-labelTreatment

Summary

To introduce initiation of glargine insulin treatment in primary care based on a patient education program. To show and compare feasibility of group education to individual education program.

Timeline

Start
2003-11
Primary completion
—
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic — Subcutaneous

Indications